Evaluation of Compliance Issues to Anti-glaucoma Medications Before and After a Structured Interventional Program.

Subhan, Irshad A; Alosaimy, Rawan; Alotaibi, Nouf T; Mirza, Bayan; Mirza, Ghufran; Bantan, Orjwan

Subhan, Irshad A; Alosaimy, Rawan; Alotaibi, Nouf T; Mirza, Bayan; Mirza, Ghufran; Bantan, Orjwan.

Afiliação

Subhan IA; Department of Ophthalmology, King Abdullah Medical City, Makkah, SAU.
Alosaimy R; Department of Medicine and Surgery, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Alotaibi NT; Department of Medicine and Surgery, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Mirza B; Department of Medicine and Surgery, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Mirza G; Department of Pediatrics, Maternity and Children's Hospital, Al-Madinah, SAU.
Bantan O; Department of Medicine and Surgery, Batterjee Medical College, Jeddah, SAU.

Cureus ; 14(6): e25943, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35844344

Palavras-chave

anti-glaucoma medications; drug compliance; eyedrops; glaucoma; improve patient outcomes; patient education

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Qualitative_research Aspecto: Implementation_research Idioma: En Revista: Cureus Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google